Bangrui Biotech Q4 2025 Financial Report
NQ Score
67/100
N1 Content Completeness
7
AI Summary (NQ-processed)
Bangrui Biotech Co., Ltd. reported a basic EPS of NT$ 4.13 for Q4 2025. The company achieved operating revenue of NT$ 306 million and a net income after tax of NT$ 103 million.
AI analysis data is not yet available.